Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2012 2
2014 1
2017 1
2020 2
2021 6
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Sec61 Inhibitor Apratoxin S4 Potently Inhibits SARS-CoV-2 and Exhibits Broad-Spectrum Antiviral Activity.
Pohl MO, Martin-Sancho L, Ratnayake R, White KM, Riva L, Chen QY, Lieber G, Busnadiego I, Yin X, Lin S, Pu Y, Pache L, Rosales R, Déjosez M, Qin Y, De Jesus PD, Beall A, Yoh S, Hale BG, Zwaka TP, Matsunaga N, García-Sastre A, Stertz S, Chanda SK, Luesch H. Pohl MO, et al. Among authors: busnadiego i. ACS Infect Dis. 2022 Jul 8;8(7):1265-1279. doi: 10.1021/acsinfecdis.2c00008. Epub 2022 Jun 29. ACS Infect Dis. 2022. PMID: 35766385 Free PMC article.
An antiviral trap made of protein nanofibrils and iron oxyhydroxide nanoparticles.
Palika A, Armanious A, Rahimi A, Medaglia C, Gasbarri M, Handschin S, Rossi A, Pohl MO, Busnadiego I, Gübeli C, Anjanappa RB, Bolisetty S, Peydayesh M, Stertz S, Hale BG, Tapparel C, Stellacci F, Mezzenga R. Palika A, et al. Among authors: busnadiego i. Nat Nanotechnol. 2021 Aug;16(8):918-925. doi: 10.1038/s41565-021-00920-5. Epub 2021 Jun 3. Nat Nanotechnol. 2021. PMID: 34083772
Manipulation of the unfolded protein response: A pharmacological strategy against coronavirus infection.
Echavarría-Consuegra L, Cook GM, Busnadiego I, Lefèvre C, Keep S, Brown K, Doyle N, Dowgier G, Franaszek K, Moore NA, Siddell SG, Bickerton E, Hale BG, Firth AE, Brierley I, Irigoyen N. Echavarría-Consuegra L, et al. Among authors: busnadiego i. PLoS Pathog. 2021 Jun 17;17(6):e1009644. doi: 10.1371/journal.ppat.1009644. eCollection 2021 Jun. PLoS Pathog. 2021. PMID: 34138976 Free PMC article.
SARS-CoV-2 variants reveal features critical for replication in primary human cells.
Pohl MO, Busnadiego I, Kufner V, Glas I, Karakus U, Schmutz S, Zaheri M, Abela I, Trkola A, Huber M, Stertz S, Hale BG. Pohl MO, et al. Among authors: busnadiego i. PLoS Biol. 2021 Mar 24;19(3):e3001006. doi: 10.1371/journal.pbio.3001006. eCollection 2021 Mar. PLoS Biol. 2021. PMID: 33760807 Free PMC article.
Host and viral determinants of Mx2 antiretroviral activity.
Busnadiego I, Kane M, Rihn SJ, Preugschas HF, Hughes J, Blanco-Melo D, Strouvelle VP, Zang TM, Willett BJ, Boutell C, Bieniasz PD, Wilson SJ. Busnadiego I, et al. J Virol. 2014 Jul;88(14):7738-52. doi: 10.1128/JVI.00214-14. Epub 2014 Apr 23. J Virol. 2014. PMID: 24760893 Free PMC article.
16 results